An observational study in Otitis Media With Effusion, sponsored by Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan. Completed. Per ClinicalTrials.gov, last updated 2024-05-07.
Sponsored by Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan · Observational
Otitis media with effusion (OME) is thought to be associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to characterize the risk of undergoing OME surgery. This retrospective, matched-cohort study involved the retrospective recruitment of patients from 2009 to 2020, using the Taiwan National Health Insurance Research Database (NHIRD)
88 studies on the registry are indexed under Otitis Media with Effusion; 17 are open to participants now.
This study's enrollment of 100,622 is above the median of 150 across 21 observational studies indexed under Otitis Media with Effusion.
Browse Otitis Media with Effusion studies →Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
All study subjects with OME-confirmed by at least two outpatient visits or one hospitalization record within NHIRD database. We excluded cases that did not meet the following criteria: patients who had undergone OME surgery before the index date, individuals younger than 4 years old, patients with unknown demographic information, individuals in the comparison cohort with a history of T2I diseases, and patients with a history of ear surgery or congenital ear anomalies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The number of participants with OME who requiring surgical intervention
surgical intervention including procedures such as myringotomy and adenoidectomy
Time frame: 10 years
No study locations are listed for this record.
Ran from Jan 2009 to primary completion in Dec 2020, 143 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan